$ADHD to Release First Quarter Financial Results


Alcobra Ltd. to Release First Quarter Financial Results and Host Corporate Update Conference Call & Webcast on May 16

Alcobra Ltd. (ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that it will report its financial results for the first quarter ended March 31, 2016 before the market open, and will host a corporate update conference call and webcast on Monday, May 16, at 8:30 am Eastern Time.
Conference Call & Webcast
Monday, May 16, 2016 @ 8:30am Eastern Time
Domestic: 855-469-0611
International: 484-756-4341
Passcode: 97907530
Webcast: http://www.alcobra-pharma.com/events.cfm
Replays available through May 30, 2016
Domestic: 855-859-2056
International: 404-537-3406
Passcode: 97907530

About Alcobra

Alcobra Ltd. is an emerging pharmaceutical company primarily focused on the development and commercialization of a proprietary drug candidate, MDX, to treat cognitive disorders including ADHD and FXS. For more information please visit the Company’s website, www.alcobra-pharma.com, the content of which is not incorporated herein by reference.


Please enter your comment!
Please enter your name here